addenda and errata\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

8-Chloro-5-(4-methyl­piperazin-1-yl)-11H-pyrido­[2,3-b][1,5]­benzoxazepine. Erratum

CROSSMARK_Color_square_no_text.svg

aUnité de Cristallographie, Institut de Physique – bât. B5, Université de Liège, Allée du 6 août, 17, B-4000 Liège, Belgium, and bCentre de Recherches en Pharmacochimie des Substances Naturelles et Synthétiques, Laboratoire de Chimie Pharmaceutique, Institut de Pharmacie – bât. B36, Université de Liège, Avenue de l'Hôpital, 1, B-4000 Liège, Belgium
*Correspondence e-mail: leon.dupont@ulg.ac.be

(Received 31 October 2003; accepted 7 November 2003; online 7 February 2004)

In the paper by Dupont & Liégeois [Acta Cryst. (2003), E59, o1962–o1963.], there is an error in the chemical name given in the title. The correct title is `8-Chloro-5-(4-methyl­piperazin-1-yl)pyrido­[2,3-b][1,5]­benzoxazepine'.

1.

2.

Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds